Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
AbbVie (NY: ABBV)
67.45 USD  +1.04 (+1.57%)
Streaming Delayed Price  /  Updated: 9:05 AM EDT, Aug 21, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 21,467
Open 67.35
Bid (Size) 67.35 (1)
Ask (Size) 67.48 (9)
Prev. Close 66.41
Today's Range 66.41 - 67.60
52wk Range 62.66 - 100.23
Shares Outstanding 1,586,879,451
Dividend Yield 5.32%
Performance
YTD
-24.41%
-24.41%
1 Month
-0.81%
-0.81%
3 Month
-16.60%
-16.60%
6 Month
-16.23%
-16.23%
1 Year
-30.91%
-30.91%
Top News
More News
Cancer Drugs Projected to Generate the Most in Pharma Revenues
Financialnewsmedia.com News Commentary Read More
from PR Newswire
Cancer Drugs Projected to Generate the Most in Pharma Revenues
category Featured News
from FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
More News
Read More
AbbVie Receives FDA Approval of RINVOQ™ (upadacitinib), an Oral JAK Inhibitor For The Treatment of Moderate to Severe Rheumatoid Arthritis
from PR Newswire
IXJ, LLY, ABBV, DHR: Large Outflows Detected at ETF
category ETFs
from ETF Channel
The Time is Right For This Dividend ETF
category ABBV , NOBL , Dividend ETF , and 2 more.
from ETF Trends
The Week Ahead In Biotech: FDA Goes Into Overdrive In A Quiet Week
category News , CSTL , TROV , and 15 more.
from Benzinga
UPDATE 2-AbbVie prices new rheumatoid arthritis drug at $59,000/yr
category companyNews
from Reuters: Company News
AbbVie's Latest FDA Approval Is Its Most Important Immunology Win Since Humira
category AGN , ABBV , Market News
from Motley Fool
UPDATE 1-FDA approves AbbVie's new rheumatoid arthritis drug
category companyNews
from Reuters: Company News
5 Biggest New Drug Approvals Potentially on the Way in 2019
category CELG , NVS , XLRN , and 4 more.
from Motley Fool
FDA approves AbbVie's new rheumatoid arthritis drug
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.